Assessing the Safety and Tolerability of NMN in DHDDS-CDG
Assessing the Safety and Tolerability of NMN in DHDDS-CDG
Recruiting · NCT07572825 · Registry updated 2026-06-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Assessing the Safety and Tolerability of NMN in DHDDS-CDG | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, DHDDS-CDG, Nutritional and Metabolic Diseases, congenital disorder of glycosylation, hereditary disease, inborn carbohydrate metabolic disorder, inborn errors of metabolism, metabolic disease | Recruiting | Phase 1 | 2026-06-22 | NCT07572825 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Eva Morava-Kozicz | 4 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Icahn School of Medicine at Mount Sinai | New York | United States | 342 |